Category:
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
Cresilon advises the financing will support the company's efforts to aggressively accelerate its global expansion plan and bring its revolutionary hemostatic gel to the human health market.
Monteris Medical Announces $73 Million in Combined Equity and Debt Financing
Monteris Medical notes the proceeds of this financing will be used to continue to support the rapid adoption of the NeuroBlate® System, an MR-guided laser ablation system that allows for a minimally invasive surgical alternative to open craniotomies.
FineHeart Awarded €2.5 Mil Grant by the EC Under the Highly Selective EIC Accelerator Program
FineHeart notes this grant has the potential to be followed by an equity investment of up to €15 million by the EIC Fund at the company’s next series C funding round. It will support the industrialization and clinical trials of the ICOMS FLOWMAKER®.
FEMSelect Secures US$9M Series B Financing
Debbie Garner, Co-CEO of FEMSelect, commented, "This investment is a testament to our team and the EnPlace® system. It enables us to expand the medical and patient communities and to serve many more women who are seeking a minimally invasive treatment option. This is a tremendous step forward for the company."
Garvis Raises €3.5 Mil Euros for a Bionic AI Platform to Optimize Supply Chain Management
Garvis notes investors include British investment funds Superseed and Scalebridge Capital, and the German group Bosch Ventures.
Axis Spine Technologies Raises £10.8m After Successful Product Release in US
The funding, which follows the successful release of its first product in the US, will enable Axis Spine Technologies to expand to new hospitals, broaden its product portfolio, and position itself as a leader in anterior lumbar surgery.
Delphinus Raises $30 Million in Series D Funding to Transform Dense Breast Screening
The round drew participation from both new and existing investors, including Arboretum Ventures, Beringea, North Coast Technology Investors, Venture Investors, Hopen Life Science Ventures, and Waycross Ventures.
Signum Surgical Secures Additional €2.9 Mil
Funds to support ongoing regulatory submissions and clinical programs leading to the commercialization of BioHealx reports Signum Surgical.
Elevation Spine, Inc. Closes $11 Million Series B Financing
Elevation Spine plans to use the proceeds from the financing to ramp the commercial production of Saber-C® as well as support product development of future product extensions of the company’s Saber® Technology platform of products.
Medical Device News Magazine
